Cargando…
Current and New Predictors for Treatment Response in Metastatic Colorectal Cancer. The Role of Circulating miRNAs as Biomarkers
Colorectal cancer (CRC) is the third most frequently diagnosed cancer in the world. More than half of all CRC patients will eventually develop metastases and require treatment accordingly, but few validated predictive factors for response to systemic treatments exist. In order to ascertain which pat...
Autores principales: | Gherman, Alexandra, Balacescu, Loredana, Gheorghe-Cetean, Sinziana, Vlad, Catalin, Balacescu, Ovidiu, Irimie, Alexandru, Lisencu, Cosmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139554/ https://www.ncbi.nlm.nih.gov/pubmed/32197436 http://dx.doi.org/10.3390/ijms21062089 |
Ejemplares similares
-
The Role of Circulating Tumor Cells in Chemoresistant Metastatic Breast Cancer
por: Lisencu, Lorena Alexandra, et al.
Publicado: (2021) -
The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases
por: Balacescu, Ovidiu, et al.
Publicado: (2018) -
The Role of Circulating Tumor Cells in the Prognosis of Metastatic Triple-Negative Breast Cancers: A Systematic Review of the Literature
por: Lisencu, Lorena Alexandra, et al.
Publicado: (2022) -
Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer
por: Gherman, Alexandra, et al.
Publicado: (2023) -
The Role of PDGFs and PDGFRs in Colorectal Cancer
por: Manzat Saplacan, Roberta M., et al.
Publicado: (2017)